PIK3CA and breast carcinoma: Cell lines with wildtype PIK3CA were less sensitive or lacked sensitivity to GDC-0941 completely, in agreement with studies in breast cancer, multiple myeloma, lung cancer, and endometrial cancer, where PIK3CA mutations are also frequent [25, 26, 51].